drugset / Trial / NCT00686127

Symptom Management After Breast Cancer Surgery

NCT00686127 ↗

Phase 4 Completed 21 enrolled University of California, San Francisco
RandomizedParallel-groupDouble-blindSupportive care

Summary

This trial is part of a larger, longitudinal study of symptoms that occur in the breast surgical scar area and/or ipsilateral arm following breast cancer surgery. Women who develop pain in the breast scar area or ipsilateral arm will be randomized to a placebo patch or a lidocaine patch that they will wear on a daily basis for 12 weeks. We hypothesize that women who wear the lidocaine patch will report a decrease in pain and decreased interference with function compared to women who wear the placebo patch.

Timeline

Start
2003-09
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 5 % Topical

Indications